Joint Suite

This page is for registered veterinary surgeons only. Veterinary medicines available to all veterinarians. For more information on these products please contact the Randlab office or your local veterinary medicines wholesaler. For inquiries outside of Australia check with your local Randlab office for supply and registration status.

Zycan® Injection 
For treatment of lameness due to degenerative aseptic joint
disease in horses.
Product information sheet Safety Data Sheet Zycan Brochure

Active Constituents

Polysulfated Glycosaminoglycan 100 mg/mL



Indications

Zycan is a Disease Modifying Osteoarthritis Drug (DMOAD) for the treatment and prevention of clinical signs attributable to degenerative and/or traumatic aseptic joint disease in horses. DMOADs are intended to prevent, retard or reverse the morphologic cartilaginous lesions associated with degenerative joint disease (DJD).

PSGAGs, such as Zycan have been advocated for the (i) preventative treatment of joint disease (ii) chronic joint maintenance programs and (iii) post-operative care of horses returning to training following joint surgery.


Pack Size

7 x 5mL Vials per carton

Share by: